Briefly answer the question:
Exome sequencing to identify a mutation that could cause a particular set of symptoms in a patient can reveal another genetic condition that has not yet been detected. Under what circumstances, if any, do you think patients should receive such "secondary findings"?
Already registered? Login
Not Account? Sign up
Enter your email address to reset your password
Back to Login? Click here